AI Article Synopsis
- In 2010, a review detailed the role of TGFβ proteins in diabetes, highlighting many unanswered questions.
- The updated review revisits this topic, confirming earlier findings and introducing new evidence from the last decade.
- Significant advancements include human data and studies on other TGFβ family members, as well as the discovery of mechanisms that can increase β-cell numbers, challenging previous beliefs about transdifferentiation.
Article Abstract
In 2010, we published a review summarizing the role of the transforming growth factor-beta (TGFβ) family of proteins in diabetes. At that time there were still many outstanding questions that needed to be answered. In this updated review, we revisit the topic and provide new evidence that supports findings from previous studies included in the 2010 review and adds to the knowledge base with new findings and information. The most substantial contributions in the past 10 years have been in the areas of human data, the investigation of TGFβ family members other than activin [e.g., bone morphogenetic proteins (BMPs), growth and differentiation factor 11 (GDF11), nodal], and the expansion of β-cell number through various mechanisms including transdifferentiation, which was previously believed to not be possible.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.tem.2020.11.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!